Valeant Pharmaceuticals International, Inc., April 29, 2017

April 29, 2017

The hearing before Justice Chantal Chatelaine for authorization and leave to proceed with statutory claims on behalf of purchasers on the secondary market has concluded. Justice Chatelaine has reserved her decision.

---